-
Hermia will be available on booths of Canon, Siemens and Spectrum Dynamics at RSNA 2024
Hermes Medical Solutions (HMS), a leader in molecular imaging software development will demonstrate its true vendor-neutral character through partnerships at this year’s RSNA to provide customers of Canon Medical Systems, Siemens Healthineers and Spectrum Dynamics Medical with access to the Hermia software.
-
Hermes Medical Solutions Receives 510(k) FDA Clearance for its Hermia NM Processing (Hybrid Viewer)
Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions receives 510(k) FDA Clearance for its Hybrid Viewer 7.0. The product has previously been CE-marked and holds a medical device license from Health Canada.
-
Witness the exciting Hermia news at the Hermes Medical Solutions booth at EANM 2024
Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions is excited to showcase all new and upcoming product updates to the All-in-One Molecular Imaging Software Suite Hermia at EANM 2024.
-
Hermia Dosimetry will be available on Siemens’ booth through syngo.via at EANM 2024
Hermes Medical Solutions (HMS), a leader in molecular imaging software development, and Siemens Healthineers, a global provider of healthcare equipment, solutions, and services, will demonstrate their partnership at this year’s EANM to provide Siemens Healthineers customers with access to Hermia dosimetry products.
-
Hermes Medical Solutions releases a new version of Hermia Voxel Dosimetry
Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, launches the latest version of Hermia Voxel Dosimetry.
-
Canon Medical Systems USA, Inc. and Hermes Medical Solutions Sign Sales Agent Agreement Ahead of SNMMI 2024
[Tustin, CA, June 6, 2024]—Canon Medical Systems USA, Inc. and Hermes Medical Solutions have announced a strategic partnership by signing a Sales Agent Agreement just before the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 conference. This collaboration marks a significant milestone in advancing precision medicine, particularly in theranostics. It aims to broaden access to innovative solutions and improve clinical outcomes for all patients.
Press releases